跳至主要内容
临床试验/NCT00598130
NCT00598130已完成2 期

A Prospective, Randomized, Single-Blind, Standard Care Controlled, Multi-Center, Phase II Study Evaluating the Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

OMRIX Biopharmaceuticals4 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
4
主要终点
Proportion of successes at 10 minutes following randomization

研究概览

简要总结

This is a prospective, randomized, single blind, standard care- controlled study, which will include a total of 30 patients divided into two treatment arms: First are: patents who will be treated in accordance with standard of care. Second arm: patients for which the Fibrin Fleece will be applied directly on the active bleeding site.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective open partial nephrectomy
  • Patients must be willing to participate in the study, and provide written informed consent

排除标准

  • Patients with a tumor diameter greater than 4 cm
  • Any additional surgical intervention other than partial nephrectomy
  • Patients with only one functional kidney
  • Patients with known intolerance to blood products or other components of the product

结局指标

主要结局

Proportion of successes at 10 minutes following randomization

时间窗: 10 minutes

次要结局

  • Proportion of successes at 5 minutes following randomization(5 minutes)

研究者

申办方类型
Industry

研究点 (4)

Loading locations...

相似试验